Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02323191
Title A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

stomach cancer

urinary bladder cancer

Her2-receptor negative breast cancer

ovarian cancer

sarcoma

Therapies

Atezolizumab + Emactuzumab

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.